Article Text
Correction
Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Statistics from Altmetric.com
Martens AWJ, Janssen SR, Derks IAM, et al. CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells. J Immunother Cancer 2020;8:e000218. doi: 10.1136/jitc-2019-000218
This paper has been updated since first published to update Figure 5I. One patient was removed from the figure since the patient originally labeled as chronic lymphocytic leukemia, has been recently re-diagnosed as indolent CD5 +mantle cell lymphoma.